Welcome to Medications.com

Enbrel Information

What's inside Enbrel

Enbrel Active Ingredients: etanercept, details.
Enbrel Dosages & Strengths
Strength Format Route Strength Class
Enbrel 25 mg powder for injection subcutaneous 1.0 each OTC
Enbrel 50 mg/mL solution subcutaneous 1.0 milliliter(s) OTC

Recent Enbrel Side Effects

Posted by footloose about 1 year ago
Has anyone experienced uncontrollable diarrhea? My mom recently went off of Enbrel and has had terrible diarrhea. It starte...

Posted by sascha65 about 1 year ago
My husband is currently injecting enbrel, I am concerned with his mood swings and lack of desire. He also complains of feelin...

Posted by kiwi99 about 1 year ago
My Mom just died on June 24, 2008 of a massive heart attack....out of NOWHERE....no prior heart problems... She had been o...


Enbrel in the News

Growing pains: Sixth-grader doesn't let arthritis get in her way - Belleville News Democrat
Now she takes Enbrel and Arava, to relieve her pain. So far, none of her siblings has shown signs of arthritis. "The best medication is exercise," Moore ...
Sun Mar 09 06:37:03 -0400 2008

Pelosi's ETHA bill and Amgen - American Thinker
That drug called Enbrel is used as an inhibitor in cases of severe psoriasis among other conditions. Many HIV patients develop psoriasis and other ...
Thu Mar 06 01:17:53 -0500 2008

Watery Pools In Bone Marrow Key To Psoriatic Arthritic Damage - Science Daily (press release)
In the current study, researchers examined the molecular effects of etanercept (Enbrel), a genetically engineered drug produced by Amgen and approved by the ...
Thu Mar 06 11:34:58 -0500 2008


Enbrel Chemical Information

etanercept - A recombinant soluble dimeric fusion protein consisting of the extracellular ligand-binding region of recombinant human tumor necrosis factor (rhTNF) receptor attached to the constant (Fc) region of human immunoglobulin G (FcIgG). The receptor moiety of etanercept binds to circulating TNF (2 molecules of TNF per receptor) and inhibits its attachment to endogenous TNF cell surface receptors, thereby rendering TNF inactive and inhibiting TNF-mediated mechanisms of inflammation. (NCI04)




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea